z-logo
open-access-imgOpen Access
mTOR Inhibition Induces Compensatory, Therapeutically Targetable MEK Activation in Renal Cell Carcinoma
Author(s) -
Sean T. Bailey,
B. Zhou,
Jeffrey S. Damrauer,
Bhavani Krishnan,
Harper L. Wilson,
Aleisha M. Smith,
MingQing Li,
Jen Jen Yeh,
William Y. Kim
Publication year - 2014
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - Uncategorized
DOI - 10.17615/qcvm-v108
Subject(s) - pi3k/akt/mtor pathway , renal cell carcinoma , cancer research , discovery and development of mtor inhibitors , medicine , biology , microbiology and biotechnology , signal transduction

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom